Jianjun Xu
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
-
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 3
- Genomics and Chromatin Dynamics 3
- Glycosylation and Glycoproteins Research 2
- RNA modifications and cancer 2
-
- Ferroptosis and cancer prognosis 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)Experimental Cell Research (1 paper)Journal of Cellular Physiology (1 paper)
In The Last Decade
Jianjun Xu
17 papers receiving 345 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 159
- Molecular Biology 284
- Oncology 55
- Immunology 39
- Pulmonary and Respiratory Medicine 40
Countries citing papers authored by Jianjun Xu
This map shows the geographic impact of Jianjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Xu more than expected).
Fields of papers citing papers by Jianjun Xu
This network shows the impact of papers produced by Jianjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Xu. The network helps show where Jianjun Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianjun Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mutations in the TTN Gene are a Prognostic Factor for Patients with Lung Squamous Cell Carcinomas | 2022 | 19 |
| 2 | 2022 | 12 | |
| 3 | 2021 | 33 | |
| 4 | 2021 | 16 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 10 | |
| 7 | The effect of the overexpression of miR-490 on the biological function of prostate cancer cell PC-3. | 2020 | 2 |
| 8 | 2018 | 66 | |
| 9 | 2018 | 18 | |
| 10 | 2018 | 9 | |
| 11 | Schizandrin B protects LPS-induced sepsis via TLR4/NF-κB/MyD88 signaling pathway. | 2018 | 33 |
| 12 | 2017 | 20 | |
| 13 | 2017 | 16 | |
| 14 | 2017 | 35 | |
| 15 | 2016 | 15 | |
| 16 | 2014 | 9 | |
| 17 | 2013 | 13 |
About Jianjun Xu
Jianjun Xu is a scholar working on Cancer Research, Molecular Biology and Biotechnology, having authored 17 papers that have together received 345 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Ubiquitin and proteasome pathways (3 papers), Genomics and Chromatin Dynamics (3 papers), Glycosylation and Glycoproteins Research (2 papers), Ferroptosis and cancer prognosis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (159 citations), Molecular Biology (284 citations) and Oncology (55 citations). Jianjun Xu has collaborated with scholars based in China, Japan and Ethiopia. Frequent co-authors include Qingyun Zhang, Yue Meng, Yiping Wei, Xiang Long, Yin Wu, Pengfei Zhang, Zhengjun Liu, Tingting Wang, Bai‐Quan Qiu and Shu‐Qiang Zhu. Their work appears in journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.